ImmunoMet Therapeutics' Incubator/Accelerator Round

ImmunoMet Therapeutics raised a round of funding on March 02, 2016. Investors include JLabs.

ImmunoMet Therapeutics is a development-stage biotechnology company focused on utilizing cellular metabolism to develop anti-tumor and immuno-oncology therapies.…

Articles about ImmunoMet Therapeutics' Incubator/Accelerator Round: